Related Experiment Videos
Hyperkalemia in hospitalized patients
1Department of Medicine and Pharmacology, Creighton University, Omaha, Nebraska, USA.
International Urology and Nephrology
|March 7, 2001
Summary
Hyperkalemia (high potassium) affects 3.3% of hospitalized patients not on dialysis. It is linked to older age, diabetes, reduced kidney function, and ACE inhibitor use, indicating higher mortality risk from underlying conditions.
Area of Science:
- Nephrology
- Internal Medicine
- Clinical Pharmacology
Background:
- Hyperkalemia, defined as serum potassium > 5.5 mmol/l, is a common electrolyte disturbance.
- Its prevalence and associated risk factors in hospitalized patients not on dialysis require further investigation.
Purpose of the Study:
- To determine the prevalence of hyperkalemia in hospitalized adults not on dialysis.
- To identify medications, renal function, and comorbid conditions associated with hyperkalemia.
Main Methods:
- Retrospective case-control study.
- Involved adult patients not on dialysis at a tertiary care teaching hospital.
- Compared medication use and renal function (creatinine clearance) between hyperkalemic patients and matched controls.
Main Results:
- Prevalence of hyperkalemia was 3.3% in the study population.
- Hyperkalemic patients were older, had lower creatinine clearance, and were more likely to use ACE inhibitors and have diabetes mellitus.
- Mortality rate was 17% in the hyperkalemic group versus 0% in controls (p < 0.0001).
Conclusions:
- Hyperkalemia is associated with older age, diabetes mellitus, impaired renal function, and ACE inhibitor use.
- Elevated serum potassium may signal increased mortality risk due to underlying conditions, not hyperkalemia itself.
- Hyperkalemia in hospitalized patients warrants careful evaluation of associated risk factors and comorbidities.